Biology subjects

Littler, D. R.

Publications and source records attributed to Littler, D. R..

2 recordsLinked to original sources

bioRxiv2025

Self-iterative multiple instance learning enables the prediction of CD4+ T cell immunogenic epitopes

Accurately predicting the antigen presentation to CD4+ T cells and subsequent induction of immune response is fundamentally important for vaccine development, autoimmune disease treatments, and cancer neoepitope identification. In immunopeptidomics, single-allelic data are highly specific but limited in allele scope, while multi-allelic data contain broader coverage at the cost of weakly labeling. Existing computational approaches either overlook the massive multi-allelic data or introduce label ambiguity due to inadequate modeling strategies. Here, we introduce ImmuScope, a weakly supervised deep-learning framework integrating precise MHC-II antigen presentation, CD4+ T cell epitopes, and immunogenicity predictions. ImmuScope leverages self-iterative multiple-instance learning with positive-anchor triplet loss to explore peptide-MHC-II (pMHC-II) binding from weakly labeled multi-allelic data and single-allelic data, comprising over 600,000 ligands across 142 alleles. Moreover, ImmuScope can also interpret the MHC-II binding specificity and motif deconvolution of immunopeptidomics data. We successfully applied ImmuScope to discover melanoma neoantigens, revealing variations in pMHC-II binding and immunogenicity upon epitope mutations. We further employed ImmuScope to assess the effects of SARS-CoV-2 epitope mutations on immune escape, with its predictions aligned well with experimentally determined immune escape dynamics. Overall, ImmuScope provides a comprehensive solution for CD4+ T cell antigen recognition and immunogenicity assessment, with broad potential for advancing vaccine design and personalized immunotherapy.

bioinformatics↗

bioRxiv2024

Epitope-anchored contrastive transfer learning for paired CD8+ T cell receptor-antigen recognition

Understanding the mechanisms of T-cell antigen recognition that underpin adaptive immune responses is critical for the development of vaccines, immunotherapies, and treatments against autoimmune diseases. Despite extensive research efforts, the accurate identification of T cell receptor (TCR)-antigen binding pairs remains a significant challenge due to the vast diversity and cross-reactivity of TCRs. Here, we propose a deep-learning framework termed Epitope-anchored Contrastive Transfer Learning (EPACT) tailored to paired human CD8+ TCRs from single-cell sequencing data. Harnessing the pre-trained representations and the contrastive co-embedding space, EPACT demonstrates state-of-the-art model generalizability in predicting TCR binding specificity for unseen epitopes and distinct TCR repertoires, offering potential values for practical outcomes in real-world scenarios. The contrastive learning paradigm achieves highly precise predictions for immunodominant epitopes and facilitates interpretable analysis of epitope-specific T cells. The TCR binding strength predicted by EPACT aligns well with the surge in spike-specific immune responses targeting SARS-CoV-2 epitopes after vaccination. We further fine-tune EPACT on TCR-epitope structural data to decipher the residue-level interactions involved in T-cell antigen recognition. EPACT not only exhibits superior capabilities in quantifying inter-chain distance matrices and identifying contact residue pairs but also corroborates the presence of molecular mimicry across multiple tumor-associated antigens. Together, EPACT can serve as a useful AI approach with significant potential in practical applications and contribute toward the development of TCR-based diagnostics and immunotherapies.

bioinformatics↗